FDA, CISA advise on genomic device software vulnerabilities

FDA, CISA advise on genomic device software vulnerabilities

A software patch is available to prevent cybersecurity threats to patient care, genomic data and provider networks from software vulnerabilities in Illumina’s benchtop and production-scale genomic sequencing instruments.

A software patch is available to prevent cybersecurity threats to patient care, genomic data and provider networks from software vulnerabilities in Illumina’s benchtop and production-scale genomic sequencing instruments.


Go to Source
2023-04-28 19:03

Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.

Author: admin